Also known as: MST-16; Perazolin
Sobuzoxane is an oral antineoplastic agent that acts as a catalytic inhibitor of DNA topoisomerase II. It is used in the treatment of various hematological malignancies, particularly T-cell lymphoma. Mediocon Inc manufactures pharmaceutical-grade Sobuzoxane API at its GMP-certified Aurangabad facility.
| Parameter | Specification |
|---|---|
| CAS Number | 98631-95-9 |
| Molecular Formula | C₂₀H₂₈N₄O₈ |
| Molecular Weight | 456.46 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Antineoplastic / Topoisomerase II Inhibitor |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |